Extended interval dosing of natalizumab in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 87(8): 885-9, 2016 Aug.
Article
in En
| MEDLINE
| ID: mdl-26917698
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukoencephalopathy, Progressive Multifocal
/
Natalizumab
/
Multiple Sclerosis
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurol Neurosurg Psychiatry
Year:
2016
Type:
Article
Affiliation country:
United States